sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.
SB-421a-006
Phase 2 small_molecule active
Quick answer
sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe. for Retinitis Pigmentosa is a Phase 2 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- Retinitis Pigmentosa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active